TW290458B - - Google Patents

Info

Publication number
TW290458B
TW290458B TW083101988A TW83101988A TW290458B TW 290458 B TW290458 B TW 290458B TW 083101988 A TW083101988 A TW 083101988A TW 83101988 A TW83101988 A TW 83101988A TW 290458 B TW290458 B TW 290458B
Authority
TW
Taiwan
Application number
TW083101988A
Original Assignee
Yeda Res & Dev
Ramont University Authority For Applied Res And Industr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev, Ramont University Authority For Applied Res And Industr filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of TW290458B publication Critical patent/TW290458B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
TW083101988A 1993-03-16 1994-03-08 TW290458B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL10506193A IL105061A (en) 1993-03-16 1993-03-16 Pharmaceutical compositions for the treatment of neurodegenerative diseases comprising VIP analogues and fragments thereof

Publications (1)

Publication Number Publication Date
TW290458B true TW290458B (zh) 1996-11-11

Family

ID=11064619

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083101988A TW290458B (zh) 1993-03-16 1994-03-08

Country Status (7)

Country Link
EP (1) EP0620008B1 (zh)
JP (1) JPH0769919A (zh)
KR (1) KR100305453B1 (zh)
CN (1) CN1140294C (zh)
DE (1) DE69418931T2 (zh)
IL (1) IL105061A (zh)
TW (1) TW290458B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL118003A0 (en) * 1996-04-23 1996-08-04 Yeda Res & Dev Novel vip fragments and pharmaceutical compositions comprising them
FR2775902B1 (fr) * 1998-03-13 2001-05-11 Assist Publ Hopitaux De Paris Utilisation d'analogues du vip dans la prevention et le traitement des lesions cerebrales du nouveau-ne humain
US6713445B1 (en) * 1998-04-06 2004-03-30 Advanced Immuni T, Inc. Peptides for treatment of HIV infection
US20020115605A1 (en) * 2000-08-24 2002-08-22 Matthew During Novel peptide with effects on cerebral health
CN101229363A (zh) 2000-11-28 2008-07-30 蒙多生物技术许可股份公司 具有血管活性肠肽的生物学活性的用于治疗肺动脉和小动脉高压的化合物
DE60326723D1 (de) * 2002-06-10 2009-04-30 Mondobiotech Licensing Out Ag Verwendung von zusammensetzungen mit der biologischen aktivität der vasoaktiven intestinalen peptide zur behandlung von sarcoidose
US20100062969A1 (en) * 2006-04-07 2010-03-11 Hayat Onyuksel Hydrophilic polymer-conjugated lipids for peptide and protein folding disorders
KR101242066B1 (ko) 2010-05-19 2013-03-12 강원대학교산학협력단 Ｖｉｐ를 유효성분으로 함유하는 기분장애 예방 및 치료용 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0563304A4 (en) * 1990-12-21 1994-09-14 Univ Case Western Reserve Neuronal cholinergic differentiation factor
IL99924A (en) * 1991-10-31 1995-12-31 Yeda Res & Dev Derivatives of structurally modified vip and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
IL105061A0 (en) 1993-07-08
IL105061A (en) 2000-11-21
EP0620008A1 (en) 1994-10-19
DE69418931D1 (de) 1999-07-15
DE69418931T2 (de) 2000-03-16
KR940021074A (ko) 1994-10-17
CN1140294C (zh) 2004-03-03
JPH0769919A (ja) 1995-03-14
EP0620008B1 (en) 1999-06-09
KR100305453B1 (ko) 2001-11-22
CN1100327A (zh) 1995-03-22

Similar Documents

Publication Publication Date Title
FR2709599B1 (zh)
FR2706747B1 (zh)
FR2706976B1 (zh)
FR2712297B1 (zh)
FR2713975B1 (zh)
FR2709800B1 (zh)
GB9306672D0 (zh)
FR2706981B1 (zh)
DK0611885T3 (zh)
DK22893A (zh)
TW290458B (zh)
FR2706898B1 (zh)
FR2706802B1 (zh)
FR2707016B1 (zh)
FR2706953B1 (zh)
FR2706944B1 (zh)
FR2706843B3 (zh)
FR2706742B1 (zh)
FR2707056B1 (zh)
IN179544B (zh)
IN174539B (zh)
IN177305B (zh)
ECSDI930113S (zh)
IN178723B (zh)
IN178359B (zh)